International Forum on Organoid Research and Personalized Medicine
IFORPM
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest innovations in organoid technology, focusing on the methodologies that enhance the generation and manipulation of organoids. Participants will discuss the implications of these advancements for personalized medicine and regenerative therapies.
SDG 3
SDG 4
This track will delve into the application of organoids in modeling various diseases, including cancer and genetic disorders. Researchers will present their findings on how organoid systems can replicate disease pathology and inform therapeutic strategies.
SDG 3
SDG 9
This session will highlight the intersection of stem cell research and organoid development, examining how stem cells contribute to organoid formation and functionality. Discussions will focus on the implications for regenerative medicine and tissue engineering.
SDG 3
SDG 9
This track will focus on the translational aspects of organoid research, emphasizing the pathway from laboratory discoveries to clinical applications. Presentations will cover case studies that illustrate successful transitions from bench to bedside.
SDG 3
SDG 9
This session will investigate the role of organoid platforms in advancing precision medicine, particularly in tailoring treatments to individual patient profiles. Participants will discuss how organoids can be utilized for drug screening and personalized therapeutic approaches.
SDG 3
SDG 9
This track will address the ethical implications surrounding organoid research, including issues of consent, ownership, and the potential for organoid-derived therapies. Experts will engage in discussions on establishing ethical guidelines for future research.
SDG 16
This session will explore the potential of organoids in regenerative medicine, focusing on their ability to replace damaged tissues and organs. Researchers will present innovative approaches to harnessing organoids for therapeutic purposes.
SDG 3
SDG 9
This track will highlight the current and potential clinical applications of organoid technology in various medical fields. Presenters will share insights on how organoids can inform treatment decisions and improve patient outcomes.
SDG 3
SDG 9
This session will examine the integration of organoids into tissue engineering frameworks, discussing strategies to enhance tissue functionality and viability. Researchers will present collaborative efforts that bridge organoid technology with engineering principles.
SDG 3
SDG 9
This track will focus on the utilization of organoids as models for drug discovery, emphasizing their ability to mimic human physiology and disease states. Participants will discuss how organoid-based assays can improve the efficiency and efficacy of drug development.
SDG 3
SDG 9
This session will provide a forward-looking perspective on the future of organoid research, highlighting emerging trends and technologies. Experts will discuss potential breakthroughs and the challenges that lie ahead in the field of personalized medicine.
SDG 3
SDG 9